Leica Bond Ready-to-Use Primary Antibody CDX2 (AMT28); an in vitro diagnostic immunohistochemistry primary antibody kit; Catalog No. PA0535; Leica Biosystems Newcastle Ltd., Balliol Business Park West, Benton Lane, Newcastle Upon Tyne NE12 8EW, United Kingdom. The CDX2 (AMT28) monoclonal antibody is intended to be used for the qualitative identification by light microscopy of human CDX2 protein in formalin-fixed, paraffin-embedded tissue by immunohistochemical staining using the automated Bond system. The clinical interpretation of any staining or its absence should be complemented by morphological studies and proper controls and should be evaluated within the context of the patient's clinical history and other diagnostic tests by a qualified pathologist.
This recall has been terminated (originally issued September 9, 2011).
- Company
- Leica Microsystems, Inc.
- Recall Initiated
- July 26, 2011
- Posted
- September 9, 2011
- Terminated
- September 9, 2011
- Recall Number
- Z-3181-2011
- Quantity
- 3 units
- Firm Location
- Buffalo Grove, IL
- Official Source
- View on FDA website ↗
Reason for Recall
There was an issue with the controlled temperature storage unit where the products were stored prior to shipment to the customers.
Distribution
Nationwide Distribution-in the states of Indiana and Kentucky.
Lot / Code Info
Catalog number PA0535, lot number 13817
Root Cause
Employee error
Action Taken
Leica Microsystems, Inc. notified all affected customers by telephone on July 26, 2011. The product, problem, and actions to be taken by the customers were discussed. Customers were instructed to discontinue use of the product and to return the product. All affected product has been returned to the firm.
More recalls by Leica Microsystems, Inc.
Leica Microsystems M220 F12 Microscope Systems
Nov 3, 2021
Leica ARveo and M530 OH6 microscope systems.
May 20, 2020